Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection

Documenti analoghi

• The Human TRIM5α Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus Capsid
  di: Perron, Michel J., et al.
  Pubblicazione: (2007)
• Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction
  di: Stremlau, Matthew, et al.
  Pubblicazione: (2005)
• Mode of Transmission Affects the Sensitivity of Human Immunodeficiency Virus Type 1 to Restriction by Rhesus TRIM5α
  di: Richardson, Max W., et al.
  Pubblicazione: (2008)
• Binding and Susceptibility to Postentry Restriction Factors in Monkey Cells Are Specified by Distinct Regions of the Human Immunodeficiency Virus Type 1 Capsid
  di: Owens, Christopher M., et al.
  Pubblicazione: (2004)
• Role of TRIM5α RING Domain E3 Ubiquitin Ligase Activity in Capsid Disassembly, Reverse Transcription Blockade, and Restriction of Simian Immunodeficiency Virus
  di: Kim, Jonghwa, et al.
  Pubblicazione: (2011)